Literature DB >> 16523358

Renal microvascular constriction to membrane depolarization and other stimuli: pivotal role for rho-kinase.

Marjon H Roos1, William F van Rodijnen, Anton A van Lambalgen, Piet M ter Wee, Geert Jan Tangelder.   

Abstract

Contraction of vascular smooth muscle is determined not only by levels of intracellular free calcium but also by the sensitivity of its contractile apparatus. A potential modulator of the latter is rho-kinase. We addressed the question of a possible central role for rho-kinase in the regulation of periglomerular microvascular tone. In the rat hydronephrotic kidney model, diameter changes of distal interlobular arteries, afferent and efferent arterioles were measured using three distinctly different stimuli: intravascular pressure changes, angiotensin II (AngII) and membrane depolarization, which is a physiological component of many signaling pathways, as evoked in two ways. Two selective, structurally different rho-kinase inhibitors, Y-27632 and HA-1077, were employed, as well as a selective protein kinase C alpha inhibitor. Preglomerular vasoconstriction induced by direct membrane depolarization, increases in pressure or AngII all depended for their effect on rho-kinase. A differing role for rho-kinase in efferent arteriolar constriction to AngII as compared to preglomerular microvessels was not found. In conclusion, our data indicate that in the kidney, rho-kinase is involved in a variety of signaling pathways leading to microvascular constriction. It plays a pivotal role not only in preglomerular but also in postglomerular tone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16523358     DOI: 10.1007/s00424-006-0053-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  21 in total

Review 1.  Isolated juxtaglomerular apparatus as a tool for exploring glomerular hemodynamics: application of microperfusion techniques.

Authors:  S Arima; S Ito
Journal:  Exp Nephrol       Date:  2000 Jul-Oct

2.  Myosin heavy chain expression in renal afferent and efferent arterioles: relationship to contractile kinetics and function.

Authors:  Mitsuya Shiraishi; Xuemei Wang; Michael P Walsh; Gary Kargacin; Kathy Loutzenhiser; Rodger Loutzenhiser
Journal:  FASEB J       Date:  2003-10-16       Impact factor: 5.191

3.  Vessel- and vasoconstrictor-dependent role of rho/rho-kinase in renal microvascular tone.

Authors:  Akira Nakamura; Koichi Hayashi; Yuri Ozawa; Keiji Fujiwara; Ken Okubo; Takeshi Kanda; Shu Wakino; Takao Saruta
Journal:  J Vasc Res       Date:  2003 May-Jun       Impact factor: 1.934

4.  Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II.

Authors:  T Takenaka; H Suzuki; K Fujiwara; Y Kanno; Y Ohno; K Hayashi; T Nagahama; T Saruta
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

5.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

6.  Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.

Authors:  T Ishizaki; M Uehata; I Tamechika; J Keel; K Nonomura; M Maekawa; S Narumiya
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

7.  Role of protein kinase C in angiotensin II-induced constriction of renal microvessels.

Authors:  T Nagahama; K Hayashi; Y Ozawa; T Takenaka; T Saruta
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

8.  Angiotensin II-mediated constriction of afferent and efferent arterioles involves T-type Ca2+ channel activation.

Authors:  Ming-Guo Feng; L Gabriel Navar
Journal:  Am J Nephrol       Date:  2004-12-23       Impact factor: 3.754

9.  RhoA/Rho kinase and nitric oxide modulate the agonist-induced pulmonary artery diameter response time.

Authors:  Christa Boer; Peter J W van der Linden; Gert Jan Scheffer; Nico Westerhof; Jaap J de Lange; Pieter Sipkema
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-03       Impact factor: 4.733

10.  Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo.

Authors:  Alessandro Cavarape; Nicole Endlich; Roberta Assaloni; Ettore Bartoli; Michael Steinhausen; Niranjan Parekh; Karlhans Endlich
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  8 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 2.  Smooth muscle contractile diversity in the control of regional circulations.

Authors:  John J Reho; Xiaoxu Zheng; Steven A Fisher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-01       Impact factor: 4.733

Review 3.  Potential benefits of rho-kinase inhibition in arterial hypertension.

Authors:  Olaf Grisk
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

4.  Rho kinase inhibitors reduce voltage-dependent Ca2+ channel signaling in aortic and renal microvascular smooth muscle cells.

Authors:  Zhengrong Guan; Joshua J Baty; Shali Zhang; Colton E Remedies; Edward W Inscho
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-21

Review 5.  P2 receptors in renal autoregulation.

Authors:  Zhengrong Guan; Robert C Fellner; Justin Van Beusecum; Edward W Inscho
Journal:  Curr Vasc Pharmacol       Date:  2014       Impact factor: 2.719

Review 6.  Druggable targets in the Rho pathway and their promise for therapeutic control of blood pressure.

Authors:  Rachel A Dee; Kevin D Mangum; Xue Bai; Christopher P Mack; Joan M Taylor
Journal:  Pharmacol Ther       Date:  2018-09-04       Impact factor: 12.310

7.  The plasma membrane potential and the organization of the actin cytoskeleton of epithelial cells.

Authors:  Silvia Chifflet; Julio A Hernández
Journal:  Int J Cell Biol       Date:  2012-01-23

8.  Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action.

Authors:  Lina Nordquist; Fredrik Palm; Bradley T Andresen
Journal:  Biologics       Date:  2008-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.